Lung-derived soluble factors reprogram the triple negative breast cancer phosphoproteome to drive metastasis via activation of CD44 and Rho-family signaling

Background Triple negative breast cancer (TNBC) is an aggressive and highly metastatic subtype of breast cancer. Lung is one of the most common sites for TNBC metastasis, suggesting that the lung microenvironment provides a conducive microenvironment or “niche” for metastatic colonization of TNBC cells. There are limited therapeutic options for treating or preventing lung metastasis, resulting in significant patient morbidity and mortality. This highlights an urgent need to better understand the molecular signaling between the metastatic microenvironment and disseminated TNBC cells. Methods To elucidate microenvironment-driven intracellular signaling events, we performed integrated quantitative global proteomics and phosphoproteomics on TNBC cells exposed to lung-conditioned media from either tumor naïve (tnLCM) or primary TNBC tumor bearing mice (tbLCM). Results Global proteomic profiling revealed an enrichment of pathways associated with extracellular matrix (ECM) remodelling, MET signaling, and metabolic remodelling in TNBC cells exposed to tbLCM. Phosphoproteomic changes in tbLCM exposed TNBC cells resembled signatures associated with altered PI3K signaling, metastasis permissive phenotype and therapy resistance. Additionally, phosphoproteomic analysis demonstrated that tbLCM selectively induces phosphorylation of CD44 at S686 and enhanced components of Rho GTPase pathway. Furthermore, using previously identified lung-derived soluble factors, we generated ligand-receptor network, which identified a highly redundant, multi-ligand network of lung-derived factors secreted specifically in the presence of primary tumor that converged on the CD44 receptor, suggesting its activation in TNBC cells in the primed lung microenvironment and potentially driving metastatic colonization via Rho GTPase signaling axis. Conclusions Together, these findings demonstrate that primed niche factors in the lung can reprogram the TNBC proteome and phosphoproteome to promote metastatic behavior. This is potentially achieved by activation of invasive CD44-Rho GTPase signaling, presenting a novel multi-nodal target for treatment of metastatic TNBC disease.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11474787/v1
Primary Topic
Cancer Cells and Metastasis
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Lung-derived soluble factors reprogram the triple negative breast cancer phosphoproteome to drive metastasis via activation of CD44 and Rho-family signaling

David B. Goodale, Matthew M. Piaseczny, Vasudeva K. Bhat, Laszlo Gyenis et al.
Research Square
Cancer Cells and Metastasis
preprint

Lung-derived soluble factors reprogram the triple negative breast cancer phosphoproteome to drive metastasis via activation of CD44 and Rho-family signaling

David B. Goodale, Matthew M. Piaseczny, Vasudeva K. Bhat, Laszlo Gyenis, Daniel Menyhart, Urvi Patel, Carl O. Postenka, David W. Litchfield, Alison L. Allan
preprint en

Abstract

Background Triple negative breast cancer (TNBC) is an aggressive and highly metastatic subtype of breast cancer. Lung is one of the most common sites for TNBC metastasis, suggesting that the lung microenvironment provides a conducive microenvironment or “niche” for metastatic colonization of TNBC cells. There are limited therapeutic options for treating or preventing lung metastasis, resulting in significant patient morbidity and mortality. This highlights an urgent need to better understand the molecular signaling between the metastatic microenvironment and disseminated TNBC cells. Methods To elucidate microenvironment-driven intracellular signaling events, we performed integrated quantitative global proteomics and phosphoproteomics on TNBC cells exposed to lung-conditioned media from either tumor naïve (tnLCM) or primary TNBC tumor bearing mice (tbLCM). Results Global proteomic profiling revealed an enrichment of pathways associated with extracellular matrix (ECM) remodelling, MET signaling, and metabolic remodelling in TNBC cells exposed to tbLCM. Phosphoproteomic changes in tbLCM exposed TNBC cells resembled signatures associated with altered PI3K signaling, metastasis permissive phenotype and therapy resistance. Additionally, phosphoproteomic analysis demonstrated that tbLCM selectively induces phosphorylation of CD44 at S686 and enhanced components of Rho GTPase pathway. Furthermore, using previously identified lung-derived soluble factors, we generated ligand-receptor network, which identified a highly redundant, multi-ligand network of lung-derived factors secreted specifically in the presence of primary tumor that converged on the CD44 receptor, suggesting its activation in TNBC cells in the primed lung microenvironment and potentially driving metastatic colonization via Rho GTPase signaling axis. Conclusions Together, these findings demonstrate that primed niche factors in the lung can reprogram the TNBC proteome and phosphoproteome to promote metastatic behavior. This is potentially achieved by activation of invasive CD44-Rho GTPase signaling, presenting a novel multi-nodal target for treatment of metastatic TNBC disease.

Research Square
Western University (CA), London Health Sciences Centre Research Institute (CA)
Cancer Cells and Metastasis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon